Study | Stated Aims | Consecutive Patients | Prospective Data Collection | End Points Appropriate to the Aims | Unbiased End Point Assessment | Appropriate Follow-up Period | <5% Loss to Follow-up | Study Size Calculation | Adequate Control Group | Contemporary Group | Baseline Equivalence Group | Statistical Analysis | Total Score |
Abe 2000 | 1 | 2 | 0 | 1 | 0 | 2 | 2 | 0 | 0 | 0 | 0 | 1 | 9 |
Boriani 2000 | 2 | 2 | 0 | 2 | 0 | 2 | 2 | 0 | 1 | 1 | 1 | 0 | 13 |
Melcher 2007 | 1 | 2 | 0 | 2 | 0 | 2 | 2 | 0 | 0 | 0 | 0 | 2 | 11 |
Kawahara 2010 | 2 | 2 | 0 | 2 | 0 | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 10 |
Liljenqvist 2010 | 1 | 2 | 0 | 2 | 2 | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 11 |
Martin 2010 | 1 | 2 | 0 | 2 | 0 | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 9 |
Disch 2011 | 1 | 2 | 2 | 0 | 2 | 0 | 2 | 2 | 0 | 0 | 0 | 0 | 12 |
Boriani 2012 | 2 | 2 | 0 | 1 | 0 | 2 | 2 | 0 | 0 | 0 | 0 | 1 | 9 |
Huang 2018 | 2 | 2 | 0 | 2 | 0 | 2 | 2 | 0 | 0 | 0 | 0 | 1 | 11 |
Xiong 2018 | 2 | 2 | 0 | 2 | 0 | 2 | 2 | 0 | 0 | 0 | 0 | 1 | 11 |
Shimuzu 2018 | 2 | 2 | 0 | 2 | 0 | 2 | 2 | 0 | 0 | 0 | 0 | 1 | 11 |
Yang 2019 | 2 | 2 | 0 | 2 | 0 | 2 | 2 | 0 | 0 | 0 | 0 | 1 | 11 |
Average score | 11 | ||||||||||||
aThe ideal MINORS scale score is 16.